| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.0003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.76 | 0.003 |